**1. Introduction**

220 Neuromuscular Disorders

Rodgers-Johanson P., Garruto R.M., Yanagihara R., Chen K.M., Gajdusek D.C.,& Gibbs C.J.

Schroder H.D.,& Reske-Nielsen E. (1984). Preservation of the nucleus – pelvic floor motor

Shaw PJ. (2005). Molecular and cellular pathways of neurodegeneration in motor neuron

Stalpers L.J., & Moser E.C. (2002). Results of radiotherapy for drooling in amyotrophic

Strong M., & Rosenfeld J. (2003). Amyotrophic lateral sclerosis: a review of current concepts.

Strong M.J., Grace G.M., Freedman M., Lomen-Hoerth C, Woolley S, Goldstein L.H. Murphy

Swash M., Leader M., Browen A.,& Swettenhan K. (1986). Focal loss of anterior horn cells in

Takeda S., Yamada M., Kawasaki K., et al. (1994). Motor neuron disease with multi-system

Tsuchiya K., Ozawa E., Fukushima J., et al. (2000). Rapidly progressive aphasia and motor

Turner M.R., Kiernan M.C, Leigh P.N., & Talbot K. (2009). Biomarkers in amyotrophic

Valdmanis P.N., & Rouleau G.A. (2008). Genetics of familial amyotrophic lateral sclerosis.

Van der Graaff M. (2004). Amyotrophic lateral sclerosis. Orphanet Encyclopedia. September.

Washington, D.C. (c2007). The ALS Association; [updated 2008 Oct; cited 2011.Feb 17].

Wijesekera L.C. & Leigh P.N. (2009). Amyotrophic lateral sclerosis. Orphanet Journal of Rare

Winterholler M.G., Erbguth F.J., Wolf S.,& Kat S. (2001). Botulinum toxin for the treatment of

Winterholler M.G., Heckmann J.G. Hecht M. & Erbguth F.J. (2002). Recurrent trismus and

Yoshida M. (2004). Amyotrophic lateral sclerosis with dementia: The clinicopothological

Zago S., Poletti B., Morelli C., Doretti A., & Silani V. (2010). Archives italiennes de Biologie,

sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol

stridor in an ALS patient: successful treatment with botulinum toxin.

Diseases [cited 2011 Feb 17] ; 4(3) [about 22p.]. Avalilable from:

the cervical cord in motor neuron disease. Brain;109:939-52

with circumscribed lobar atrophy. Acta Neuropathol;99:81-7.

http://www.prpha.net/data/patho/GB/uk-ALS.pdf.

J. ,Shoesmith C., Rosenfeld J., Leigh P.N., Bruijn L., Ince P.,& Figlewiez D. (2009). Consensus criteria for the diagnosis of front-otemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10:131-146,. Swash M. (2001). Amyotrophic lateral sclerosis: current understanding. J Neurosci

involvement presenting as tetraparesis, ophthalmoplegia and sensori-autonomic

neuron disease: a clinical, radiological, and pathological study of an autopsy case

year evaluation and neuropathologic trends. Neurology;36:7-13.

system in amyorophic lateral sclerosis. Clin Neuropathol;3:210-6

disease. J Neurol Neurosurg Psychiatry; 76:1046-1057. Simonds A.K. (2003). Home ventitation. Eur Respir J; 22:38s-46s.

ALS and other motor neuron disorders;4:136-143

dysfunction. Acta Neuropathol;88:193-200.

lateral sclerosis. Lancet Neurol;8:94-109.

Available from http://www.alsa.org/.

http://www.ojrd.com/content/4/1/3.

Neurosurg Psychiatry;70:417-18.

spectrum, Neuropathology;24:87-102.

Talbot K. (2002). Motor neurone disease, Postgrad Med J.;78:513-519.

lateral sclerosis. Neurology;58:1308.

Nurs;33:245-53.

Neurology;70:144-52.

Neurology;58:502-03.

149;39:56,.

(1986). Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30
